Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 1.05 is 26% below its 5-year average of 1.41, near the low end of its 5-year range (0.78–3.21).
As of the fiscal period ended Tuesday, June 30, 2026. 5.79% below its 12-month average of 1.12.
Reported quarterly quick ratio; no daily interpolation. Q4 FY2026 (2026-06-30): 1.05.
QUICK RATIO (ACID-TEST)
1.05
QUICK RATIO (ACID-TEST) AVG TTM
1.12
QUICK RATIO (ACID-TEST) AVG 3Y
1.20
QUICK RATIO (ACID-TEST) AVG 5Y
1.41
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-5.79%
CURRENT VS 3Y AVG
-12.31%
CURRENT VS 5Y AVG
-25.52%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.15
median of 703 covered companies
CURRENT VS SECTOR MEDIAN
-66.63%
vs the sector median at left
Innovage Holding Corp.
Market Cap
$1.22B
Quick Ratio (Acid-Test)
1.05
TTM Avg
1.12
3Y Avg
1.20
5Y Avg
1.41
Market Cap
$1.22B
Quick Ratio (Acid-Test)
1.41
TTM Avg
2.22
3Y Avg
2.73
5Y Avg
2.72
Market Cap
$1.23B
Quick Ratio (Acid-Test)
15.25
TTM Avg
18.40
3Y Avg
18.04
5Y Avg
16.30
Market Cap
$1.16B
Quick Ratio (Acid-Test)
19.73
TTM Avg
13.53
3Y Avg
9.78
5Y Avg
15.63
Market Cap
$1.25B
Quick Ratio (Acid-Test)
13.19
TTM Avg
12.35
3Y Avg
12.19
5Y Avg
16.27
Market Cap
$1.16B
Quick Ratio (Acid-Test)
10.42
TTM Avg
4.62
3Y Avg
5.77
5Y Avg
6.99
Market Cap
$1.15B
Quick Ratio (Acid-Test)
33.10
TTM Avg
10.19
3Y Avg
10.19
5Y Avg
10.19
Market Cap
$1.15B
Quick Ratio (Acid-Test)
1.38
TTM Avg
3.96
3Y Avg
6.78
5Y Avg
9.79
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Innovage Holding Corp. (INNV) | $1.22B | 1.05 | 1.12 | 1.20 | 1.41 |
| MannKind Corporation (MNKD)vs › | $1.22B | 1.41 | 2.22 | 2.73 | 2.72 |
| Omada Health (OMDA)vs › | $1.23B | 3.85 | 2.79 | 3.53 | 3.53 |
| Cronos Group Inc. (CRON)vs › | $1.23B | 15.25 | 18.40 | 18.04 | 16.30 |
| Damora Therapeutics, Inc. (DMRA)vs › | $1.16B | 19.73 | 13.53 | 9.78 | 15.63 |
| ORIC Pharmaceuticals, Inc. (ORIC)vs › | $1.25B | 13.19 | 12.35 | 12.19 | 16.27 |
| Nektar Therapeutics (NKTR)vs › | $1.16B | 10.42 | 4.62 | 5.77 | 6.99 |
| Avalyn Pharma Inc. Common Stock (AVLN)vs › | $1.15B | 33.10 | 10.19 | 10.19 | 10.19 |
| GoodRx Holdings, Inc. (GDRX)vs › | $1.15B | 1.38 | 3.96 | 6.78 | 9.79 |
| Kardigan, Inc. (KARD)vs › | $1.30B | 8.72 | 9.20 | 9.20 | 9.20 |
Quick Ratio
1.05
Excludes inventory
Current Ratio
1.05
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 1.05 |
| 2026-03-31 | 1.03 |
| 2025-12-31 | 1.26 |
| 2025-09-30 | 1.17 |
| 2025-06-30 | 1.07 |
| 2025-03-31 | 0.78 |
| 2024-12-31 | 1.16 |
| 2024-09-30 | 1.21 |
| 2024-06-30 | 1.25 |
| 2024-03-31 | 1.25 |
| 2023-12-31 | 1.27 |
| 2023-09-30 | 1.41 |
| 2023-06-30 | 1.25 |
| 2023-03-31 | 1.57 |
| 2022-12-31 | 1.88 |
| 2022-09-30 | 1.85 |
| 2022-06-30 | 2.29 |
| 2022-03-31 | 2.65 |
| 2021-12-31 | 2.98 |
| 2021-09-30 | 3.21 |
| 2021-06-30 | 3.19 |
| 2021-03-31 | 2.68 |
| 2020-12-31 | 1.33 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 2.18 |
| 2020-03-31 | 0.00 |
